Prof. Dr. Dachel Martínez Asanza | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Prof. Dr. Dachel Martínez Asanza | Medicine | Best Researcher Award

Professor/ Senior Researcher | University of Medical Sciences of Havana | Cuba

Prof. Dr. Dachel Martínez Asanza is a distinguished Cuban scholar and senior researcher in the field of dental sciences and medical education, recognized for her interdisciplinary expertise in comprehensive dentistry, health promotion, epidemiology, and pedagogical innovation in medical education. Her academic pursuits bridge clinical dentistry with public health, emphasizing preventive oral care, biopsychosocial health management, and the integration of digital and natural medicine within community health frameworks. A full professor at the University of Medical Sciences of Havana, Dr. Asanza has made substantial contributions to advancing dental education through work-based learning methodologies and curriculum development in health sciences. Her research explores the intersection of technology, digital health, and education, reflecting a deep commitment to enhancing healthcare delivery and educational practices in dentistry. With a Scopus record of 26 indexed publications, over 143 citations from 107 documents, and an h-index of 7, alongside Google Scholar metrics of 371 total citations, an h-index of 11, and an i10-index of 12, Dr. Asanza’s scholarly impact is widely recognized. Her works are featured in reputed international journals, often addressing themes such as digital health adoption, green innovation, and AI applications in healthcare.

Profile

Scopus | ORCID | Google Scholar

Featured Publications

  • Golmankhaneh, A. K., Tunç, S., Schlichtinger, A. M., & Martínez Asanza, D. (2024). Modeling tumor growth using fractal calculus: Insights into tumor dynamics. Biosystems, 235, 105071.

  • Kamel Mouloudj, A. B., Bouarar, A. C., Martínez Asanza, D., & Linda, M. (2023). Factors influencing the adoption of digital health apps: An extended technology acceptance model (TAM). Integrating Digital Health Strategies for Effective Administration, 116–132.

  • Martínez Asanza, D. (2018). Traditional teaching in the 21st century? Neuronum Magazine, 4(1), 99–106.

  • Martínez-Asanza, D. (2021). Regarding work-based learning, a guiding principle of Cuban medical education. FEM: Journal of the Medical Education Foundation, 24(6), 325–325.

  • Njoku, A., Mouloudj, K., Bouarar, A. C., Evans, M. A., & Martínez Asanza, D. (2024). Intentions to create green start-ups for collection of unwanted drugs: An empirical study. Sustainability, 16(7), 2797.

Golnar Rahimzadeh | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Golnar Rahimzadeh | Medicine | Best Researcher Award

Mazandaran University of Medical Sciences | Iran

Assist. Prof. Dr. Golnar Rahimzadeh is an Iranian researcher and academic specializing in bacteriophage therapy, pediatric infectious diseases, and antimicrobial resistance. She currently serves as an Assistant Professor at the Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences. With a strong scientific foundation in microbiology and biotechnology, she has contributed extensively to developing innovative therapeutic approaches against drug-resistant pathogens. Her work integrates laboratory expertise, clinical research, and translational science, particularly focusing on infectious diseases in children. She is also a pioneer in developing nanotechnology-based phage therapies and advanced biomedical applications.

Publication Profile

Scopus

ORCID

Education Background

She began her academic journey with a Bachelor’s degree at Islamic Azad University in Isfahan, later pursuing a Master’s at the Science and Research Branch of Islamic Azad University in Tehran. Her dedication to microbiology and medical sciences led her to complete a Ph.D. at Mazandaran University of Medical Sciences. She further advanced her expertise through postdoctoral training at the same institution, focusing on innovative therapeutic technologies and bacteriophage applications. This academic pathway shaped her multidisciplinary perspective, combining molecular biology, biotechnology, and infectious diseases research.

Professional Experience

Assist. Prof. Dr. Golnar Rahimzadeh has held diverse professional roles, starting as a clinical and pathological laboratory expert in Isfahan and later contributing at Royan Stem Cell Technology Company in Tehran. She played an instrumental role in the Stem Cell Cord Blood Bank at Sari Birth Cohort Center, specializing in HLA typing and flow cytometry. Her academic career advanced with her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, where she leads projects in infectious disease research. She has also served as a technical assistant in pediatric laboratory settings and has been actively engaged in scientific congresses, contributing to advancing knowledge in her field.

Awards and Honors

Her distinguished achievements include her appointment as an Assistant Professor at Mazandaran University of Medical Sciences, reflecting her academic and research excellence. She has also registered a knowledge-based company, Persian Nano-Bio Therapy, specializing in the isolation and production of industrial bacteriophage strains for pharmaceutical treatments, marking a significant innovation in biotechnology. In addition, she has received recognition for her scientific contributions through participation in national congresses, international conferences, and collaborative research projects. Her innovative patents on phage-based therapies for burn wounds and infectious diseases further highlight her impact in medical biotechnology.

Research Focus

Her primary research interests lie in bacteriophage therapy, antimicrobial resistance, and pediatric infectious diseases. She has made notable contributions in developing phage-based gels, inhaled phage therapies, and nanobioparticles for combating resistant pathogens such as MRSA, Pseudomonas aeruginosa, and Acinetobacter baumannii. She is also actively involved in clinical research on COVID associated infections, nosocomial infections, and secondary bacterial pneumonia. By bridging laboratory innovations with clinical applications, her work emphasizes translational medicine aimed at developing safe, effective, and sustainable treatments against multidrug-resistant microorganisms.

Publication

Antimicrobial activity Kefir on Pseudomonas aeruginosa
Published Year: 2011
Citation: 34

Evaluation of wound healing activities of kefir products
Published Year: 2012
Citation: 97

Characterization of methicillin-resistant Staphylococcus aureus phages from sewage at a pediatric hospital
Published Year: 2016
Citation: 42

Endolysins of Bacteriophages as an Anti-Methicillin Resistant Staphylococcus aureus Infection in Children: A Narrative Review
Published Year: 2018
Citation: 19

Phage Therapy in Treatment of Gram-negative Bacterial Infections: A Systematic Review
Published Year: 2018
Citation: 63

Conclusion

Assist. Prof. Dr. Golnar Rahimzadeh stands as a leading figure in pediatric infectious disease research and phage therapy innovations. Her career reflects a balance of academic scholarship, industrial innovation, and translational medical research. With numerous publications, patents, and international collaborations, she continues to advance the global understanding of antimicrobial resistance and the therapeutic potential of bacteriophages. Her dedication to improving pediatric health through biotechnology has positioned her as an influential voice in the scientific community, making lasting contributions to both academic medicine and applied biomedical sciences.